Oxurion NV (XBRU:OXUR) Total Stockholders Equity : €-13.19 Mil (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Oxurion NV Total Stockholders Equity?

Oxurion NV's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €-13.19 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Oxurion NV's Book Value per Share for the quarter that ended in Dec. 2023 was €-0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Oxurion NV's Debt-to-Equity for the quarter that ended in Dec. 2023 was -0.94.

Oxurion NV Total Stockholders Equity Historical Data

The historical data trend for Oxurion NV's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxurion NV Total Stockholders Equity Chart

Oxurion NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

53.16

25.18

-1.08

-4.58

-13.19

Oxurion NV Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															-1.08	-1.53	-4.58	-8.62	-13.19

Oxurion NV (XBRU:OXUR) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Oxurion NV's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-13.186	-	0)	/	3489.46
	=	-0.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Oxurion NV's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(12.217	+	0.117)	/	-13.186
	=	-0.94

Oxurion NV Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Oxurion NV's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxurion NV (XBRU:OXUR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxurion NV (XBRU:OXUR) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

TG4:Germany

Address

Gaston Geenslaan 1, Leuven, BEL, B-3001

Website

https://www.oxurion.com

Oxurion NV is a clinical stage biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME). The Group's research and development facilities are located in Belgium .The Company is engaged in the development of drugs to treat back-of-the-eye diseases, more specifically, ophthalmologic pharmaceuticals to treat vascular retinal disorders, specifically DME.

Oxurion NV (XBRU:OXUR) Headlines

No Headlines